date:Feb 06, 2020
Speciality food ingredients provider Tate Lyle has invested in Zymtronix, a US-based start-up company, which develops enzyme immobilisation technologies.
Zymtronix will use the investment to enhance its enzyme immobilisation platform and increase its production capacity.
Neither company has divulged any financial information.
Tate Lyle innovation and commercial development president Andrew Taylor said: Consumers worldwide are looking for healthier food and drink and we are proud to have the